tiprankstipranks
Acrivon Therapeutics, Inc. (ACRV)
NASDAQ:ACRV
US Market
ACRV
Acrivon Therapeutics, Inc.
RESEARCH TOOLSreports

Acrivon Therapeutics, Inc. (ACRV) Stock News & Sentiment

838 Followers
Acrivon Highlights Positive ACR-368 Data and 2025 Results
Premium
Company Announcements
Acrivon Highlights Positive ACR-368 Data and 2025 Results
24d ago
8K
ACRV
ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon
Premium
Ratings
ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon
1M ago
ACRV
Acrivon Highlights Promising ACR-368 Phase 2b Endometrial Data
Premium
Company Announcements
Acrivon Highlights Promising ACR-368 Phase 2b Endometrial Data
1M ago
8K
ACRV
3 Best Stocks to Buy Today, 1/22/2026, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Today, 1/22/2026, According to Top Analysts
3M ago
ACRV
META
Balancing Early Promise and Significant Uncertainty: Maintaining a Hold on Acrivon Therapeutics Amid Limited Data and Long-Dated Clinical Risk
Premium
Ratings
Balancing Early Promise and Significant Uncertainty: Maintaining a Hold on Acrivon Therapeutics Amid Limited Data and Long-Dated Clinical Risk
3M ago
ACRV
Focused Clinical Strategy and Accelerated Approval Path for ACR-368 in High-Need Serous Endometrial Cancer Underpin ACRV Buy Rating
Premium
Ratings
Focused Clinical Strategy and Accelerated Approval Path for ACR-368 in High-Need Serous Endometrial Cancer Underpin ACRV Buy Rating
3M ago
ACRV
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
3M ago
F
AEP
More ACRV News >

ACRV News on the Web

Jefferies Keeps Their Buy Rating on Acrivon Therapeutics, Inc. (ACRV)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Scholar Rock Holding (SRRK) and Acrivon Therapeutics, Inc. (ACRV)
TipRanks News
Bullish
Acrivon Highlights Positive ACR-368 Data and 2025 Results
TipRanks News
Neutral
Acrivon plans to initiate fourth cohort in ACR-368 Phase 2b study
TipRanks News
Bullish
Acrivon Therapeutics reports Q4 EPS (49c), consensus (46c)
TipRanks News
Bullish
Acrivon Therapeutics sees cash runway into 2Q27
TipRanks News
Bullish
Acrivon Therapeutics, Inc. (ACRV) Upgraded to Buy: Here's Why
Zacks
Bullish
Piper Sandler Remains a Buy on Acrivon Therapeutics, Inc. (ACRV)
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ACRV’s Media Buzz Sentiment?
Currently, no data Available
What is ACRV’s weekly average amount of articles?
Currently, no data Available
What is ACRV’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week